Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Nutrients ; 13(5)2021 Apr 22.
Article En | MEDLINE | ID: mdl-33922242

As a natural active substance that can effectively improve blood lipid balance in the body, hypolipidemic active peptides have attracted the attention of scholars. In this study, the effect of walnut meal peptides (WMP) on lipid metabolism was investigated in rats fed a high-fat diet (HFD). The experimental results show that feeding walnut meal peptides counteracted the high-fat diet-induced increase in body, liver and epididymal fat weight, and reduce the serum concentrations of total cholesterol, triglycerides, and LDL-cholesterol and hepatic cholesterol and triglyceride content. Walnut meal peptides also resulted in increased HDL-cholesterol while reducing the atherosclerosis index (AI). Additionally, the stained pathological sections of the liver showed that the walnut meal peptides reduced hepatic steatosis and damage caused by HFD. Furthermore, walnut meal peptide supplementation was associated with normalization of elevated apolipoprotein (Apo)-B and reduced Apo-A1 induced by the high-fat diet and with favorable changes in the expression of genes related to lipid metabolism (LCAT, CYP7A1, HMGR, FAS). The results indicate that walnut meal peptides can effectively prevent the harmful effects of a high-fat diet on body weight, lipid metabolism and liver fat content in rats, and provide, and provide a reference for the further development of walnut meal functional foods.


Diet, High-Fat , Hyperlipidemias/drug therapy , Juglans/chemistry , Lipid Metabolism , Liver/metabolism , Peptides/therapeutic use , Adipocytes/drug effects , Adipocytes/pathology , Amino Acids/analysis , Animals , Apolipoproteins/metabolism , Body Weight/drug effects , Cecum/drug effects , Cecum/pathology , Cholesterol/metabolism , Energy Intake/drug effects , Epididymis/drug effects , Epididymis/pathology , Gene Expression Regulation/drug effects , Hydrolysis , Hypolipidemic Agents/pharmacology , Hypolipidemic Agents/therapeutic use , Lipid Metabolism/drug effects , Liver/drug effects , Liver/enzymology , Liver/pathology , Male , Organ Size/drug effects , Peptide Hydrolases/metabolism , Peptides/pharmacology , Rats, Sprague-Dawley
...